Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceuticals, New Technology Research and Development, Etc.
590.37M
Pharmaceuticals, New Technology Research and Development, Etc. Growth
120.85%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
China
575.37M
China Growth
115.24%
South Korea
15.00M